Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-05-20 @ 6:57 PM
Study NCT ID:
NCT00667394
Status:
COMPLETED
Last Update Posted:
2015-11-05
First Post:
2008-04-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
Sponsor:
Organization: